|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Reorganization items, net | |||||
| Deferred income taxes | |||||
| Depreciation | |||||
| Amortization of deferred debt issuance costs | |||||
| Interest payments on Series B Preferred Stock, net of debt discount accretion | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of equity investment (Note 26) | |||||
| Foreign exchange (gain) loss | |||||
| Stock compensation expense | |||||
| Pension expense | |||||
| Unrealized loss (gain) on derivatives | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts, notes and other receivables | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Obligations payable to Honeywell | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Expenditures for property, plant and equipment | |||||
| Proceeds from cross-currency swap contracts | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of Series A Preferred Stock | |||||
| Total proceeds from issuance of Series A Preferred Stock | |||||
| Proceeds from issuance of long-term debt, net of deferred financing costs | |||||
| Proceeds from revolving credit facilities | |||||
| Payments of long-term debt | |||||
| Payments of revolving credit facilities | |||||
| Payments for dividends | |||||
| Repurchases of Series A Preferred Stock | |||||
| Total repurchases of Series A Preferred Stock | |||||
| Repurchases of Common Stock | |||||
| Repayments of debtor-in-possession financing | |||||
| Excise tax on Common Stock repurchase | |||||
| Redemption of Series B Preferred stock | |||||
| Total redemption of Series B Preferred stock | |||||
| Payments for debt and revolving facility financing costs | |||||
| Other | |||||
| Net cash used for financing activities | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Income taxes paid (net of refunds and credits) | |||||
| Interest paid | |||||
| Reorganization items paid | |||||
| Issuance of Series B Preferred Stock | |||||
| Dividends declared, not paid | |||||
| Total dividends declared, not paid | |||||
Loading...